The role of cytostasis in antitumor immunity: comparison between syngeneic and allogeneic systems. 1985

M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto

Different aspects of the immune response differ with respect to sensitivity of neonatal thymectomy (NTx). The effect of thymectomy on Days 1 and 7 after birth (NTx-1, NTx-7) on antitumor immune responses to both a syngeneic and an allogeneic tumor graft was examined. The tumor used was the same, Meth A fibrosarcoma of BALB/c origin, but the mice inoculated differed. The results show that the immune response to a syngeneic tumor graft is primarily cytostatic rather than cytolytic and is relatively insensitive to neonatal thymectomy, while the response to a large dose of allogeneic tumor cells includes a cytolytic mechanism of high thymus dependence.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003433 Crosses, Genetic Deliberate breeding of two different individuals that results in offspring that carry part of the genetic material of each parent. The parent organisms must be genetically compatible and may be from different varieties or closely related species. Cross, Genetic,Genetic Cross,Genetic Crosses
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas

Related Publications

M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
February 1978, Journal of immunogenetics,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
January 1973, Neoplasma,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
May 1971, Journal of the National Cancer Institute,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
June 1982, Gan,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
January 1979, Vox sanguinis,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
October 1972, Immunology,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
January 1973, Clinical and experimental immunology,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
March 1980, Transplantation proceedings,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
December 1981, Molecular immunology,
M Mitani, and K Mori, and K Himeno, and T Matsumoto, and K Taniguchi, and K Nomoto
September 1980, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!